SEOUL, South Korea — May 2025 — Exprivé attended the BioPlus BioComplex Grand Opening Ceremony, marking a significant step in its expansion into Korea’s broader bio-healthcare and biopharmaceutical ecosystem. The event celebrated the launch of BioPlus’ new manufacturing and R&D facility, positioning Korea as a growing hub for advanced healthcare production, biotechnology, and global supply chain integration.

A Strategic Move Beyond Clinics into Bio Infrastructure

Exprivé’s participation reflects a clear strategic direction:

From

• Influencer-driven patient acquisition
• Clinic-level partnerships

To

• Integration with biotech, manufacturing, and healthcare infrastructure
• Positioning within the full medical value chain

This aligns with the broader evolution of Korea’s healthcare industry, where biopharma, medical services, and global patient flows are increasingly interconnected.

Events like BioPlus and BIOPLUS-INTERPHEX Korea serve as critical platforms connecting:

• R&D
• manufacturing
• clinical services
• global commercialization

Why BioPlus Matters

BioPlus represents a new layer of Korea’s healthcare competitiveness:

• Advanced production capabilities for bio and healthcare products
• Increasing role in global supply chains
• Strong linkage to medical tourism and treatment ecosystems

As Korea scales its presence globally, the intersection of:
biotech + clinics + global patients
is becoming the next battleground.

Exprivé’s presence at BioPlus signals early positioning in this shift.

Exprivé’s Role in the New Healthcare Stack

Exprivé is building the front-end distribution layer of Korea’s healthcare industry:

• Global patient acquisition
• Influencer-driven discovery
• Real-time engagement (Exprive Now)
• Pre-consultation and conversion (Glow Diary)

By connecting with infrastructure players like BioPlus, Exprivé extends into:

• Product ecosystem understanding (devices, pharma, skincare)
• Cross-border commercialization opportunities
• Future integration of treatment + product + experience

From MEDICON to BioPlus: Building the Full Loop

Following its presentation at KMTPA on MEDICON (Asia’s Medical Conference), Exprivé is now linking:

• Global demand (patients, influencers)
• Service providers (clinics, doctors)
• Infrastructure (biotech, manufacturing, pharma)

This creates a closed-loop ecosystem:

Discovery → Consultation → Treatment → Product → Global distribution

Industry Signal

Exprivé’s attendance at BioPlus highlights a broader trend:

Korea’s healthcare industry is no longer siloed.

It is converging into a unified ecosystem where:

• Medical tourism
• Beauty & dermatology
• Biopharma & manufacturing
• Global distribution

are tightly integrated.

About Exprivé

Exprivé is building the operating system for global patient acquisition in Korea, connecting international demand with Korean medical providers through content, community, and technology.